Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

42.04
+0.46001.11%
Pre-market: 42.230.1900+0.45%09:24 EDT
Volume:22.88M
Turnover:958.08M
Market Cap:60.93B
PE:17.03
High:42.27
Open:41.50
Low:41.39
Close:41.58
52wk High:105.65
52wk Low:41.39
Shares:1.45B
Float Shares:1.45B
Volume Ratio:1.46
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.44
PE(LYR):21.67

Loading ...

Boston Scientific Posts Strong Q2 Growth in Interventional Cardiology and Neuromodulation Divisions

Deep News
·
Jul 30

Pulmonx Corp Q2 Revenue Falls, but Beats Estimates

Reuters
·
Jul 30

Conmed Q2 Sales, Adjusted Profit Beat on Organinc Platform Growth

Reuters
·
Jul 30

Glaukos Q2 Sales Jump 50%; Raises Net Sales Forecast

Reuters
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX)

TIPRANKS
·
Jul 30

Boston Scientific is Maintained at Buy by BTIG

Dow Jones
·
Jul 30

Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading

MT Newswires Live
·
Jul 30

Boston Scientific price target lowered to $60 from $65 at Stifel

TIPRANKS
·
Jul 30

Piper Sandler Adjusts Price Target on Boston Scientific to $60 From $65

MT Newswires Live
·
Jul 30

U.S. Stocks on the MOVE-Mondelez, IDEX, Merchants Bancorp

Reuters
·
Jul 29

Boston Scientific Cuts Forecast on Product Slowdown and Competition

Benzinga Earnings
·
Jul 29

Boston Scientific Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 29

Movement Alert|Boston Scientific Falls 7.62% in Regular Trading, Watchman Demand Weakness and Lowered Full-Year Guidance Weigh on Shares

Market Focus
·
Jul 29

Boston Scientific Shares Reverse Course; Last Down 8.9% Premarket

THOMSON REUTERS
·
Jul 29

Stock Track | Boston Scientific Plunges 6.67% in Pre-market as Lowered Profit Forecast, Watchman Device Woes Spook Investors

Stock Track
·
Jul 29

Boston Scientific Exec Says Co Expects Its Electrophysiology Business to Improve "Nicely" in H2 2027

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co Expects 2027 Watchman Trends to Improve from H2 2026 Levels

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co NOW Expects Global Watchman Sales Growth to be Flat to Low Single Digits in 2026

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Second Half Watchman Revenue is Expected to Decline at a Mid- to High-Single-Digit Rate Year over Year

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co NOW Expects H2 2026 to be More "Pressured" than Originally Anticipated - Conf Call

THOMSON REUTERS
·
Jul 29